(Q46099521)

19 December 2017

title

A comparison of quantitative computerized and human panel coronary endpoint measures: implications for the design of angiographic trials (English)

1 reference

19 December 2017

1 reference

Mack WJ

1

1 reference

19 December 2017

Azen SP

series ordinal

2

1 reference

19 December 2017

Dunn M

series ordinal

3

1 reference

19 December 2017

Hodis HN

series ordinal

4

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

19 December 2017

Contemporary Clinical Trials

published in

1 reference

19 December 2017

volume

18

1 reference

19 December 2017

issue

2

1 reference

19 December 2017

page(s)

168-179

1 reference

19 December 2017

The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Evaluation of colestipol/niacin therapy with computer-derived coronary end point measures. A comparison of different measures of treatment effect

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Arteriographic assessment of coronary atherosclerosis. Review of current methods, their limitations, and clinical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Evaluation of human panelists in assessing coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Comparison of computer- and human-derived coronary angiographic end-point measures for controlled therapy trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900181-X

7 January 2021

10.1016/S0197-2456(96)00181-X

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017